CWC22 anticorps (C-Term)
Aperçu rapide pour CWC22 anticorps (C-Term) (ABIN927947)
Antigène
Voir toutes CWC22 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- KIAA1604 antibody was raised in rabbit using the C terminal of KIAA1604 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
KIAA1604 Blocking Peptide, (ABIN5614339), is also available for use as a blocking control in assays to test for specificity of this KIAA1604 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CWC22 (CWC22 Spliceosome-Associated Protein Homolog (CWC22))
-
Sujet
- KIAA1604 may be involved in pre-mRNA splicing. Synonyms: Polyclonal KIAA1604 antibody, Anti-KIAA1604 antibody, CWC22 spliceosome-associated protein homolog, S. cerevisiae antibody, EIF4GL antibody, KIAA1604 antibody, NCM antibody, fSAPb antibody.
Antigène
-